Crystal structure of the marburg virus VP35 oligomerization domain

Journal of Virology

Volumn 91, Issue 2, 2017, Pages

  Bruhn, Jessica F ^a   Kirchdoerfer, Robert N ^a   Urata, Sarah M ^b   Li, Sheng ^b   Tickle, Ian J ^c   Bricogne, Gérard ^c   Saphire, Erica Ollmann ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c GLOBAL PHASING LTD   (United Kingdom)

Author keywords

Coiled coil; Ebola virus; Filovirus; Marburg virus; Oligomerization; Phosphoprotein; RNA dependent RNA polymerase; VP35; X ray crystallography

Indexed keywords

PROTEIN VP35; UNCLASSIFIED DRUG; VIRAL PROTEIN; PROTEIN BINDING; VP35 PROTEIN, FILOVIRUS;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEUTERIUM HYDROGEN EXCHANGE; EBOLAVIRUS; HYDROPHOBICITY; IMMUNE EVASION; MARBURGVIRUS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN UNFOLDING; THERMOSTABILITY; VIRUS REPLICATION; AMINO ACID SEQUENCE; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MARBURGVIRUS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; THERMODYNAMICS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 85008699037     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01085-16     Document Type: Article

References (51)

1. Brauburger K, Hume AJ, Mühlberger E, Olejnik J. 2012. Forty-five years of Marburg virus research. Viruses 4:1878-1927. https://doi.org/10.3390/v4101878.
2. Messaoudi I, Amarasinghe GK, Basler CF. 2015. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol 13:663-676. https://doi.org/10.1038/nrmicro3524.
3. Elliott LH, Kiley MP, McCormick JB. 1985. Descriptive analysis of Ebola virus proteins. Virology 147:169-176. https://doi.org/10.1016/0042-6822(85)90236-3.
4. Mühlberger E, Lotfering B, Klenk HD, Becker S. 1998. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J Virol 72:8756-8764.
5. Ivanov I, Yabukarski F, Ruigrok RWH, Jamin M. 2011. Structural insights into the rhabdovirus transcription/replication complex. Virus Res 162: 126-137. https://doi.org/10.1016/j.virusres.2011.09.025.
6. Mühlberger E. 2007. Filovirus replication and transcription. Future Virol 2:205-215. https://doi.org/10.2217/17460794.2.2.205.
7. Ortín J, Martin-Benito J. 2015. The RNA synthesis machinery of negativestranded RNA viruses. Virology 479-480:532-544. https://doi.org/10.1016/j.virol.2015.03.018.
8. Becker S, Rinne C, Hofsass U, Klenk HD, Mühlberger E. 1998. Interactions of Marburg virus nucleocapsid proteins. Virology 249:406-417. https://doi.org/10.1006/viro.1998.9328.
9. Mühlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 73:2333-2342.
10. Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO. 2015. Assembly of the Ebola virus nucleoprotein from a chaperoned VP35 complex. Cell Rep 12:140-149. https://doi.org/10.1016/j.celrep.2015.06.003.
11. Leung DW, Borek D, Luthra P, Binning JM, Anantpadma M, Liu G, Harvey IB, Su Z, Endlich-Frazier A, Pan J, Shabman RS, Chiu W, Davey RA, Otwinowski Z, Basler CF, Amarasinghe GK. 2015. An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions. Cell Rep 11:376-389. https://doi.org/10.1016/j.celrep.2015.03.034.
12. Prins KC, Binning JM, Shabman RS, Leung DW, Amarasinghe GK, Basler CF. 2010. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. J Virol 84:10581-10591. https://doi.org/10.1128/JVI.00925-10.
13. Cárdenas WB, Loo YM, Gale M, Jr, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits α/β interferon production induced by RIG-I signaling. J Virol 80:5168-5178. https://doi.org/10.1128/JVI.02199-05.
14. Bale S, Julien JP, Bornholdt ZA, Krois AS, Wilson IA, Saphire EO. 2013. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism. J Virol 87:10385-10388. https://doi.org/10.1128/JVI.01452-13.
15. Ramanan P, Edwards MR, Shabman RS, Leung DW, Endlich-Frazier AC, Borek DM, Otwinowski Z, Liu G, Huh J, Basler CF, Amarasinghe GK. 2012. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A 109:20661-20666. https://doi.org/10.1073/pnas.1213559109.
16. Bale S, Julien JP, Bornholdt ZA, Kimberlin CR, Halfmann P, Zandonatti MA, Kunert J, Kroon GJ, Kawaoka Y, MacRae IJ, Wilson IA, Saphire EO. 2012 Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. PLoS Pathog 8:e1002916. https://doi.org/10.1371/journal.ppat.1002916.
17. Leung DW, Shabman RS, Farahbakhsh M, Prins KC, Borek DM, Wang T, Mühlberger E, Basler CF, Amarasinghe GK. 2010. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol 399:347-357. https://doi.org/10.1016/j.jmb.2010.04.022.
18. Prins KC, Delpeut S, Leung DW, Reynard O, Volchkova VA, Reid SP, Ramanan P, Cárdenas WB, Amarasinghe GK, Volchkov VE, Basler CF. 2010 Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol 84:3004-3015. https://doi.org/10.1128/JVI.02459-09.
19. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Otwinowski Z, Honzatko RB, Basler CF, Amarasinghe GK. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17:165-172. https://doi.org/10.1038/nsmb.1765.
20. Kimberlin CR, Bornholdt ZA, Li S, Woods VL, Jr, MacRae IJ, Saphire EO. 2010 Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 107:314-319. https://doi.org/10.1073/pnas.0910547107.
21. Leung DW, Ginder ND, Fulton DB, Nix J, Basler CF, Honzatko RB, Amarasinghe GK. 2009. Structure of the Ebola VP35 interferon inhibitory domain. Proc Natl Acad Sci U S A 106:411-416. https://doi.org/10.1073/pnas.0807854106.
22. Edwards MR, Liu G, Mire CE, Sureshchandra S, Luthra P, Yen B, Shabman RS, Leung DW, Messaoudi I, Geisbert TW, Amarasinghe GK, Basler CF. 2016 Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins. Cell Rep 14:1632-1640. https://doi.org/10.1016/j.celrep.2016.01.049.
23. Möller P, Pariente N, Klenk HD, Becker S. 2005. Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol 79:14876-14886. https://doi.org/10.1128/JVI.79.23.14876-14886.2005.
24. Luthra P, Jordan DS, Leung DW, Amarasinghe GK, Basler CF. 2015. Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. J Virol 89:5148-5153. https://doi.org/10.1128/JVI.03652-14.
25. Grigoryan G, Degrado WF. 2011. Probing designability via a generalized model of helical bundle geometry. J Mol Biol 405:1079-1100. https://doi.org/10.1016/j.jmb.2010.08.058.
26. Walshaw J, Woolfson DN. 2001. Socket: a program for identifying and analysing coiled-coil motifs within protein structures. J Mol Biol 307: 1427-1450. https://doi.org/10.1006/jmbi.2001.4545.
27. Lupas A, Van Dyke M, Stock J. 1991. Predicting coiled coils from protein sequences. Science 252:1162-1164. https://doi.org/10.1126/science.252.5009.1162.
28. Bruhn JF, Barnett KC, Bibby J, Thomas JM, Keegan RM, Rigden DJ, Bornholdt ZA, Saphire EO. 2014. Crystal structure of the Nipah virus phosphoprotein tetramerization domain. J Virol 88:758-762. https://doi.org/10.1128/JVI.02294-13.
29. Communie G, Crepin T, Maurin D, Jensen MR, Blackledge M, Ruigrok RW. 2013 Structure of the tetramerization domain of measles virus phosphoprotein. J Virol 87:7166-7169. https://doi.org/10.1128/JVI.00487-13.
30. Bowman MC, Smallwood S, Moyer SA. 1999. Dissection of individual functions of the Sendai virus phosphoprotein in transcription. J Virol 73:6474-6483.
31. Pickar A, Elson A, Yang Y, Xu P, Luo M, He B. 2015. Oligomerization of mumps virus phosphoprotein. J Virol 89:11002-11010. https://doi.org/10.1128/JVI.01719-15.
32. Buchan DW, Minneci F, Nugent TC, Bryson K, Jones DT. 2013. Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Res 41:W349-W357. https://doi.org/10.1093/nar/gkt381.
33. Kabsch W. 2010. Integration, scaling, space-group assignment and postrefinement. Acta Crystallogr D Biol Crystallogr 66(Pt 2):133-144. https://doi.org/10.1107/S0907444909047374.
34. Evans PR, Murshudov GN. 2013. How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr 69:1204-1214. https://doi.org/10.1107/S0907444913000061.
35. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, Eisenberg D. 2006. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103:8060-8065. https://doi.org/10.1073/pnas.0602606103.
36. Sawaya MR. 2014. Methods to refine macromolecular structures in cases of severe diffraction anisotropy. Methods Mol Biol 1091:205-214. https://doi.org/10.1007/978-1-62703-691-7_15.
37. Rämisch S, Lizatovic R, Andre I. 2015. Automated de novo phasing and model building of coiled-coil proteins. Acta Crystallogr D Biol Crystallogr 71(Pt 3):606-614. https://doi.org/10.1107/S1399004714028247.
38. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. https://doi.org/10.1107/S0907444909052925.
39. Terwilliger TC, Dimaio F, Read RJ, Baker D, Bunkoczi G, Adams PD, Grosse-Kunstleve RW, Afonine PV, Echols N. 2012. phenix.mr_rosetta: molecular replacement and model rebuilding with Phenix and Rosetta. J Struct Funct Genomics 13:81-90. https://doi.org/10.1007/s10969-012-9129-3.
40. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501. https://doi.org/10.1107/S0907444910007493.
41. Blanc E, Roversi P, Vonrhein C, Flensburg C, Lea SM, Bricogne G. 2004. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr D Biol Crystallogr 60:2210-2221. https://doi.org/10.1107/S0907444904016427.
42. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA. 2011. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67:355-367. https://doi.org/10.1107/S0907444911001314.
43. Tickle IJ, Bricogne G, Flensburg C, Keller P, Paciorek W, Sharff A, Vonrhein C. 2016. STARANISO. Global Phasing Ltd., Cambridge, United Kingdom. http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi.
44. French S, Wilson K. 1978. On the treatment of negative intensity observations. Acta Crystallogr A 34:517-525.
45. Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, Womack T, Bricogne G. 2011. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D Biol Crystallogr 67:293-302. https://doi.org/10.1107/S0907444911007773.
46. Li S, Tsalkova T, White MA, Mei FC, Liu T, Wang D, Woods VL, Jr, Cheng X. 2011. Mechanism of intracellular cAMP sensor Epac2 activation: cAMPinduced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Biol Chem 286: 17889-17897. https://doi.org/10.1074/jbc.M111.224535.
47. Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL, Jr, Saphire EO. 2011 Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion. PLoS Negl Trop Dis 5:e1395. https://doi.org/10.1371/journal.pntd.0001395.
48. Olal D, Dick A, Woods VL, Jr, Liu T, Li S, Devignot S, Weber F, Saphire EO, Daumke O. 2014. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein. Nucleic Acids Res 42: 6025-6037. https://doi.org/10.1093/nar/gku229.
49. Stuart DI, Levine M, Muirhead H, Stammers DK. 1979. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å. J Mol Biol 134: 109-142. https://doi.org/10.1016/0022-2836(79)90416-9.
50. Retief JD. 2000. Phylogenetic analysis using PHYLIP. Methods Mol Biol 132:243-258.
51. Unni S, Huang Y, Hanson RM, Tobias M, Krishnan S, Li WW, Nielsen JE, Baker NA. 2011. Web servers and services for electrostatics calculations with APBS and PDB2PQR. J Comput Chem 32:1488-1491. https://doi.org/10.1002/jcc.21720.